You have accessJournal of UrologyKidney Cancer: Localized I1 Apr 2014PD16-07 THE IMPACT OF BODY MASS INDEX ON RENAL FUNCTIONAL OUTCOMES FOLLOWING MINIMALLY INVASIVE PARTIAL NEPHRECTOMY Kyle Richards, Edris Negron, Joshua Cohn, Zoe Steinberg, Scott Eggener, and Arieh Shalhav Kyle RichardsKyle Richards More articles by this author , Edris NegronEdris Negron More articles by this author , Joshua CohnJoshua Cohn More articles by this author , Zoe SteinbergZoe Steinberg More articles by this author , Scott EggenerScott Eggener More articles by this author , and Arieh ShalhavArieh Shalhav More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.1152AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail Introduction and Objectives Partial nephrectomy is the standard of care for the management of small renal masses and is increasingly performed via minimally invasive partial nephrectomy (MIPN). Obesity is a known risk factor for kidney cancer and can make surgery more challenging. Our aim is to assess the impact of body mass index (BMI) on perioperative and renal functional outcomes in patients undergoing MIPN. Methods In our IRB-approved, prospectively maintained database, we identified 1,206 patients who underwent kidney surgery from August 2002 until March 2013. Follow up has been maintained every 6 months for 2 years, and yearly thereafter with axial imaging at the discretion of the physician. Estimated glomerular filtration rate (eGFR) was obtained at baseline and at each follow-up visit. From this group, patients that underwent MIPN with more than 12 months of follow up were selected. Exclusion criteria included missing preoperative eGFR or conversion to radical nephrectomy. Patients were separated into 4 cohorts based on BMI: 1. BMI <25 kg/m2, 2. BMI 25-30 kg/m2, 3. BMI 30-35 kg/m2, and 4. BMI >35 kg/m2. Change in eGFR was compared across variables via univariate and multivariate regression models. Results 235 patients met inclusion criteria with overall median follow-up of 17 months [IQR 7, 37]. There was no difference in follow-up, baseline demographic, clinical, perioperative, or pathologic features across BMI groups. Increasing BMI was associated with a significant absolute reduction in eGFR at 1 year on univariate analysis (0.44 mL/min/BSA reduction in GFR per 1 kg/m2 increase in BMI, p=0.008). BMI (p=0.046), CCI (p=0.007), tumor size (p=0.012), and preoperative eGFR (p<0.01) were independently associated with significant absolute reduction in eGFR in a multivariate model adjusted for gender, race, BMI, CCI, warm ischemia time, and preoperative eGFR. Controlling for the same variables, gender (p=0.05), BMI by category (p=0.035), CCI (p=0.041), and preoperative eGFR (p<0.01) were independently associated with increased odds of being chronic kidney disease stage ≥ III at 1 year Conclusions MIPN is feasible in obese patients with similar perioperative outcomes to non-obese patients. BMI is an independent risk factor for worsening kidney function following MIPN, and these patients should be counseled accordingly. © 2014FiguresReferencesRelatedDetails Volume 191Issue 4SApril 2014Page: e489 Advertisement Copyright & Permissions© 2014MetricsAuthor Information Kyle Richards More articles by this author Edris Negron More articles by this author Joshua Cohn More articles by this author Zoe Steinberg More articles by this author Scott Eggener More articles by this author Arieh Shalhav More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract